BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 253708)

  • 1. Nonsurgical closure of patent ductus arteriosus in preterm infants.
    Smith ME
    Heart Lung; 1979; 8(2):308-10. PubMed ID: 253708
    [No Abstract]   [Full Text] [Related]  

  • 2. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis.
    Heymann MA; Rudolph AM; Silverman NH
    N Engl J Med; 1976 Sep; 295(10):530-3. PubMed ID: 950959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic problems with indomethacin in preterm infants with persistent ductus arteriosus].
    Seyberth HW; Müller H; Wille L; Plückthun H; Ulmer HE; Wolf D
    Monatsschr Kinderheilkd; 1983 Feb; 131(2):71-6. PubMed ID: 6843560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indomethacin for closure of patent ductus arteriosus in preterm neonates.
    Nair PA; Karan S
    Indian J Pediatr; 1986; 53(4):499-503. PubMed ID: 3804391
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug therapy of patent ductus arteriosus in premature and newborn infants].
    Bartel J
    Kinderarztl Prax; 1978 Dec; 46(12):644-8. PubMed ID: 366238
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacologic closure of patent ductus arteriosus in the premature infant.
    Friedman WF; Hirschklau MJ; Printz MP; Pitlick PT; Kirkpatrick SE
    N Engl J Med; 1976 Sep; 295(10):526-9. PubMed ID: 820994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indomethacin therapy in premature infants with patent ductus arteriosus.
    Rasidi C; Madiyono B; Usman IN
    Paediatr Indones; 1982; 22(3-4):70-6. PubMed ID: 7122105
    [No Abstract]   [Full Text] [Related]  

  • 8. [Closure of persistent ductus arteriosus in premature infants by drug therapy].
    Hencz P; Kertész E; Beviz J; Szeleczki T; Szekeres Z
    Orv Hetil; 1981 Oct; 122(41):2535-40. PubMed ID: 7033879
    [No Abstract]   [Full Text] [Related]  

  • 9. [Indomethacin for closure of persisting ductus arteriosus in the premature infant].
    Linderkamp O; Versmold HT
    Monatsschr Kinderheilkd; 1981 Feb; 129(2):118-20. PubMed ID: 6112670
    [No Abstract]   [Full Text] [Related]  

  • 10. [An alternative in the management of patent ductus arteriosus using indomethacin in premature newborn infants].
    Lozano González CH; Holden AM; Hurtado del Río D; Segura MA
    Bol Med Hosp Infant Mex; 1982 Aug; 39(8):570-5. PubMed ID: 7182006
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical treatment of the ductus arteriosus.
    Rudolph AM; Heymann MA
    Hosp Pract; 1977 Feb; 12(2):57-65. PubMed ID: 557025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indomethacin treatment of persistent ductus arteriosus in premature infants].
    Petersen S; Christensen NC; Lauridsen P; Pedersen SA; Ryssing E
    Ugeskr Laeger; 1983 Nov; 145(46):3564-7. PubMed ID: 6649140
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics and clinical efficacy of indomethacin in premature infants with patent ductus arteriosus.
    Regazzi MB; Rondanelli R; Vidale E; Chirico G; Rondini G; Chiara A; Piccolo A
    Int J Clin Pharmacol Res; 1984; 4(2):109-12. PubMed ID: 6469435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary aquaporin-2 excretion during ibuprofen or indomethacin treatment in preterm infants with patent ductus arteriosus.
    Li Y; Zelenina M; Plat-Willson G; Marcoux MO; Aperia A; Casper C
    Acta Paediatr; 2011 Jan; 100(1):59-66. PubMed ID: 21143292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacologic treatment of patent ductus arteriosus in premature infants].
    Vázquez C; Cabrera A; Pastor E; Valls y Soler A
    An Esp Pediatr; 1983 Jun; 18(6):482-8. PubMed ID: 6625369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of patent ductus arteriosus in preterm infants].
    Jaso E; Tejedor JC; Quero J; Pérez Rodríguez J; Agustí B; Castro J; García Frías E
    An Esp Pediatr; 1982 Jun; 16(6):449-58. PubMed ID: 7125398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment.
    Hammerman C
    Clin Perinatol; 1995 Jun; 22(2):457-79. PubMed ID: 7671547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with intravenous indomethacin of symptomatic ductus arteriosus in premature newborn infants].
    Valls i Soler A; Benito J; Pastor E; López Heredia I; Santiago M; Cabrera A
    An Esp Pediatr; 1987 Aug; 27(2):112-6. PubMed ID: 3662265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
    Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
    Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.